Hyperfine HYPR
NASDAQ HYPR
$0.72 -0.01 (-0.72%)
As of: Oct 23, 2026 · 3:48 PM EDT

Hyperfine (HYPR) Amortization of Deferred Charges (2026)

Updated

Analysis

Hyperfine (HYPR) Amortization of Deferred Charges (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.42 Bn 228.44 Bn 4.88 Bn
2 Abbott Laboratories 180.76 Bn 151.19 Bn 7.27 Bn
3 Danaher 161.73 Bn 145.54 Bn 3.61 Bn
4 Intuitive Surgical 157.87 Bn 138.16 Bn 2.08 Bn
5 Medtronic 122.55 Bn 87.80 Bn 6.34 Bn
6 Stryker 118.05 Bn 104.16 Bn 4.50 Bn
7 Boston Scientific 67.09 Bn 61.86 Bn 3.85 Bn
8 Becton Dickinson 54.81 Bn 51.96 Bn 2.32 Bn
9 Edwards Lifesciences 51.46 Bn 35.47 Bn 1.35 Bn
10 Hyperfine 72.13 Mn -68.75 Mn 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 112,000.00
Mar 31, 2026 17,000.00
API Access

Hyperfine Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=HYPR&period=max&api_key=YOUR_API_KEY